179 related articles for article (PubMed ID: 12972955)
1. Differential expression and function of CYP2C isoforms in human intestine and liver.
Läpple F; von Richter O; Fromm MF; Richter T; Thon KP; Wisser H; Griese EU; Eichelbaum M; Kivistö KT
Pharmacogenetics; 2003 Sep; 13(9):565-75. PubMed ID: 12972955
[TBL] [Abstract][Full Text] [Related]
2. Induction of CYP2C genes in human hepatocytes in primary culture.
Gerbal-Chaloin S; Pascussi JM; Pichard-Garcia L; Daujat M; Waechter F; Fabre JM; Carrère N; Maurel P
Drug Metab Dispos; 2001 Mar; 29(3):242-51. PubMed ID: 11181490
[TBL] [Abstract][Full Text] [Related]
3. Identification of the polymorphically expressed CYP2C19 and the wild-type CYP2C9-ILE359 allele as low-Km catalysts of cyclophosphamide and ifosfamide activation.
Chang TK; Yu L; Goldstein JA; Waxman DJ
Pharmacogenetics; 1997 Jun; 7(3):211-21. PubMed ID: 9241661
[TBL] [Abstract][Full Text] [Related]
4. Novel Cytochrome P450 2C119 Enzymes in Cynomolgus and Rhesus Macaques Metabolize Progesterone, Diclofenac, and Omeprazole.
Uno Y; Murayama N; Yamazaki H
Drug Metab Dispos; 2024 Feb; 52(3):266-273. PubMed ID: 38123944
[TBL] [Abstract][Full Text] [Related]
5. Characterization of CYP2C19 and CYP2C9 from human liver: respective roles in microsomal tolbutamide, S-mephenytoin, and omeprazole hydroxylations.
Lasker JM; Wester MR; Aramsombatdee E; Raucy JL
Arch Biochem Biophys; 1998 May; 353(1):16-28. PubMed ID: 9578596
[TBL] [Abstract][Full Text] [Related]
6. Human CYP2C19 is a major omeprazole 5-hydroxylase, as demonstrated with recombinant cytochrome P450 enzymes.
Karam WG; Goldstein JA; Lasker JM; Ghanayem BI
Drug Metab Dispos; 1996 Oct; 24(10):1081-7. PubMed ID: 8894508
[TBL] [Abstract][Full Text] [Related]
7. Expression and induction of CYP2C P450 enzymes in primary cultures of human hepatocytes.
Raucy JL; Mueller L; Duan K; Allen SW; Strom S; Lasker JM
J Pharmacol Exp Ther; 2002 Aug; 302(2):475-82. PubMed ID: 12130704
[TBL] [Abstract][Full Text] [Related]
8. Hepatocyte nuclear factor 4{alpha} regulates rifampicin-mediated induction of CYP2C genes in primary cultures of human hepatocytes.
Rana R; Chen Y; Ferguson SS; Kissling GE; Surapureddi S; Goldstein JA
Drug Metab Dispos; 2010 Apr; 38(4):591-9. PubMed ID: 20086032
[TBL] [Abstract][Full Text] [Related]
9. Activity and mRNA expression levels of selected cytochromes P450 in various sections of the human small intestine.
Clermont V; Grangeon A; Barama A; Turgeon J; Lallier M; Malaise J; Michaud V
Br J Clin Pharmacol; 2019 Jun; 85(6):1367-1377. PubMed ID: 30817016
[TBL] [Abstract][Full Text] [Related]
10. CYP2C19 participates in tolbutamide hydroxylation by human liver microsomes.
Wester MR; Lasker JM; Johnson EF; Raucy JL
Drug Metab Dispos; 2000 Mar; 28(3):354-9. PubMed ID: 10681382
[TBL] [Abstract][Full Text] [Related]
11. The prognostic value of CYP2C subfamily genes in hepatocellular carcinoma.
Wang X; Yu T; Liao X; Yang C; Han C; Zhu G; Huang K; Yu L; Qin W; Su H; Liu X; Peng T
Cancer Med; 2018 Apr; 7(4):966-980. PubMed ID: 29479826
[TBL] [Abstract][Full Text] [Related]
12. Global pharmacogenomics: Impact of population diversity on the distribution of polymorphisms in the CYP2C cluster among Brazilians.
Suarez-Kurtz G; Genro JP; de Moraes MO; Ojopi EB; Pena SD; Perini JA; Ribeiro-dos-Santos A; Romano-Silva MA; Santana I; Struchiner CJ
Pharmacogenomics J; 2012 Jun; 12(3):267-76. PubMed ID: 21173785
[TBL] [Abstract][Full Text] [Related]
13. Gene structure of CYP2C8 and extrahepatic distribution of the human CYP2Cs.
Klose TS; Blaisdell JA; Goldstein JA
J Biochem Mol Toxicol; 1999; 13(6):289-95. PubMed ID: 10487415
[TBL] [Abstract][Full Text] [Related]
14. Analyses of CYP2C in porcine microsomes.
Skaanild MT; Friis C
Basic Clin Pharmacol Toxicol; 2008 Nov; 103(5):487-92. PubMed ID: 18803635
[TBL] [Abstract][Full Text] [Related]
15. Metabolic characterization of the major human small intestinal cytochrome p450s.
Obach RS; Zhang QY; Dunbar D; Kaminsky LS
Drug Metab Dispos; 2001 Mar; 29(3):347-52. PubMed ID: 11181505
[TBL] [Abstract][Full Text] [Related]
16. Inhibitory effects of cytochrome P450 enzymes CYP2C8, CYP2C9, CYP2C19 and CYP3A4 by Labisia pumila extracts.
Pan Y; Tiong KH; Abd-Rashid BA; Ismail Z; Ismail R; Mak JW; Ong CE
J Ethnopharmacol; 2012 Sep; 143(2):586-91. PubMed ID: 22885070
[TBL] [Abstract][Full Text] [Related]
17. Differential expression of cytochrome P450 enzymes from the CYP2C subfamily in the human brain.
Booth Depaz IM; Toselli F; Wilce PA; Gillam EM
Drug Metab Dispos; 2015 Mar; 43(3):353-7. PubMed ID: 25504503
[TBL] [Abstract][Full Text] [Related]
18. Linkage disequilibrium between the CYP2C19*17 allele and wildtype CYP2C8 and CYP2C9 alleles: identification of CYP2C haplotypes in healthy Nordic populations.
Pedersen RS; Brasch-Andersen C; Sim SC; Bergmann TK; Halling J; Petersen MS; Weihe P; Edvardsen H; Kristensen VN; Brøsen K; Ingelman-Sundberg M
Eur J Clin Pharmacol; 2010 Dec; 66(12):1199-205. PubMed ID: 20665013
[TBL] [Abstract][Full Text] [Related]
19. Detection of human CYP2C8, CYP2C9, and CYP2J2 in cardiovascular tissues.
Delozier TC; Kissling GE; Coulter SJ; Dai D; Foley JF; Bradbury JA; Murphy E; Steenbergen C; Zeldin DC; Goldstein JA
Drug Metab Dispos; 2007 Apr; 35(4):682-8. PubMed ID: 17220242
[TBL] [Abstract][Full Text] [Related]
20. Gene structure and upstream regulatory regions of human CYP2C9 and CYP2C18.
de Morais SM; Schweikl H; Blaisdell J; Goldstein JA
Biochem Biophys Res Commun; 1993 Jul; 194(1):194-201. PubMed ID: 8333835
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
